{"filing":{"accession_number":"0001125345-26-000042","cik":"0001125345","ticker":"MGNX","company_name":"MACROGENICS INC","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"mgnx-20260519.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534526000042/mgnx-20260519.htm"},"events":[{"id":9753,"run_id":8550,"accession_number":"0001125345-26-000042","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of MacroGenics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting outcomes for four proposals: election of four Class I directors (all elected), ratification of Ernst \u0026 Young LLP as independent auditor (approved), advisory approval of named executive officer compensation (approved), and amendment to the 2023 Equity Incentive Plan to increase available shares by 1,250,000 (approved). The detailed vote tallies for each proposal are the core content of this Item 5.07 disclosure.","company_name":"MACROGENICS INC","ticker":"MGNX","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":544,"accession_number":"0001125345-26-000042","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of MacroGenics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting outcomes for four proposals: election of four Class I directors (all elected), ratification of Ernst \u0026 Young LLP as independent auditor (approved), advisory approval of named executive officer compensation (approved), and amendment to the 2023 Equity Incentive Plan to increase available shares by 1,250,000 (approved). The detailed vote tallies for each proposal are the core content of this Item 5.07 disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:44:18.504401+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":544,"accession_number":"0001125345-26-000042","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of MacroGenics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting outcomes for four proposals: election of four Class I directors (all elected), ratification of Ernst \u0026 Young LLP as independent auditor (approved), advisory approval of named executive officer compensation (approved), and amendment to the 2023 Equity Incentive Plan to increase available shares by 1,250,000 (approved). The detailed vote tallies for each proposal are the core content of this Item 5.07 disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:44:18.504401+00:00","company_name":"MACROGENICS INC","ticker":"MGNX","filing_date":"2026-05-20"}]}